Crossmark

Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-023-07896-8

Published Online: 2024-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soleimanzadeh, Mahsa

Talebi, Saeedeh

Jaafari, Mahmoud Reza

Sayedi, Seyed Javad

Emadzadeh, Maryam

Kianifar, Hamid Reza
Funding

Funding for this research was provided by:

Mashhad University of Medical Sciences
License Information

Text and Data Mining valid from 2024-01-16

Version of Record valid from 2024-01-16
More Information

Article History

Received: 29 March 2023

Accepted: 19 December 2023

First Online: 16 January 2024

Declarations

:

: Ethical approval was obtained from MUMS Ethics Committee. The ethical approval code is IR.MUMS.MEDICAL.REC.1401.116. Informed consent will be obtained from all the study participants or their legal guardians.

: No personal-identifying details will be published.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below